Biologic license application

Results: 93



#Item
41AdvaMed Advanr rfd Medlt ;I/ Technology Assoclatioq  October 18,2004

AdvaMed Advanr rfd Medlt ;I/ Technology Assoclatioq October 18,2004

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-11-05 15:30:47
42OMB INFORMATION COLLECTION SUPPORTING STATEMENT New Drug and Biological Drug Products; Evidence Needed to Demonstrate Efficacy of New Drugs for Use Against Lethal or Permanently Disabling Toxic Substances When Efficacy S

OMB INFORMATION COLLECTION SUPPORTING STATEMENT New Drug and Biological Drug Products; Evidence Needed to Demonstrate Efficacy of New Drugs for Use Against Lethal or Permanently Disabling Toxic Substances When Efficacy S

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2000-01-07 07:23:47
43Reference Product Exclusivity for Biological Products Filed Under Section 351(a) of the PHS Act

Reference Product Exclusivity for Biological Products Filed Under Section 351(a) of the PHS Act

Add to Reading List

Source URL: patentdocs.typepad.com

Language: English - Date: 2014-08-14 01:02:03
44DEPARTMENT OF HEALTH & HUMAN SERVICES  Public Health Service Food and Drug Administration Rockville MD 20857

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville MD 20857

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2003-12-08 14:30:51
45Health / Biologic License Application / Center for Biologics Evaluation and Research / Pharmaceutical industry / Regulatory requirement / Center for Drug Evaluation and Research / Abbreviated New Drug Application / Structured Product Labeling / Prescription Drug User Fee Act / Food and Drug Administration / Pharmaceutical sciences / Medicine

OMB INFORMATION COLLECTION SUPPORTING STATEMENT

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-10-06 10:05:35
46VIA HAND DELIVERY Division of Dockets Management U.S. Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD[removed]Re:

VIA HAND DELIVERY Division of Dockets Management U.S. Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD[removed]Re:

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-05-04 15:43:27
47Reference Product Exclusivity for Biological Products Filed Under Section 351(a) of the PHS Act

Reference Product Exclusivity for Biological Products Filed Under Section 351(a) of the PHS Act

Add to Reading List

Source URL: www.fda.gov

Language: English
48Microsoft Word - 2920A0CD.doc

Microsoft Word - 2920A0CD.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
49SOPP 8406: Managing PDUFA User Fee Payments and Billing Activities

SOPP 8406: Managing PDUFA User Fee Payments and Billing Activities

Add to Reading List

Source URL: www.fda.gov

Language: English
50Appendix 1 APLB - Advertising and Promotional Labeling Branch BiMo - Bioresearch Monitoring Branch, Division of Inspection and Surveillance, Office of Compliance and Biologics Quality BLA - biological license application

Appendix 1 APLB - Advertising and Promotional Labeling Branch BiMo - Bioresearch Monitoring Branch, Division of Inspection and Surveillance, Office of Compliance and Biologics Quality BLA - biological license application

Add to Reading List

Source URL: www.fda.gov

Language: English